The Cancer Letter

The leading source for information on the issues that shape oncology since 1973

BACK TO CONTRIBUTORS
Stephen J. Forman

Stephen J. Forman, MD

Director, Hematologic Malignancies Research Institute, Professor, Department of Hematology & Hematopoietic Cell Transplantation, Director, T Cell Therapeutics Research Laboratory, Co-director, Hematologic Malignancies Program, City of Hope Comprehensive Cancer Center; Professor, Department of Medical Oncology & Therapeutics Research, City of Hope

Latest Stories
Guest Editorial
Approximately 21 years ago, I had the privilege of working and helping to pass Proposition 71, which authorized $3 billion dollars in state bonds to fund stem cell research in California. 
By Stephen J. Forman
Sponsored
Nearly five decades ago, I joined City of Hope’s nascent bone marrow transplant (BMT) program, which focused on improving outcomes for patients with advanced leukemia. 
By Stephen J. Forman
Sponsored
This year marks the 49th anniversary of the City of Hope bone marrow transplant program, which was conceived and developed by Ernest Beutler and Karl Blume in 1975, with help and inspiration from E. Donnall Thomas, the 1990 Nobel Laureate in Physiology and Medicine.
By Stephen J. Forman

Never miss an issue!

Get alerts for our award-winning coverage in your inbox.

Login

Site license subscribers:
Log in with your IP | Register a sponsored account